Prime Editing

Prime editing is a genome engineering technique that achieves precise DNA edits without requiring double-strand breaks or donor DNA templates. Developed by Andrew Anzalone and David Liu in 2019, it uses a catalytically impaired Cas9 nickase fused to a reverse transcriptase. A prime editing guide RNA (pegRNA) both targets the edit and encodes the desired sequence change, which the reverse transcriptase writes directly into the genomic DNA at the nick site.

The system is effectively a molecular word processor: it can perform all twelve types of point mutation, plus small insertions and deletions, with substantially fewer off-target effects than conventional CRISPR. By avoiding double-strand breaks, prime editing sidesteps the cell's error-prone repair pathways — the primary source of unintended mutations in standard CRISPR editing.

However, prime editing is not universally applicable. It is most efficient for small edits (up to a few dozen base pairs). Larger insertions still require conventional homology-directed repair. And the delivery problem — getting the large prime editing machinery into target cells in vivo — remains a significant barrier to therapeutic application.

Prime editing represents the culmination of a trend in genome engineering: the progressive replacement of biological processes with information processes. Where CRISPR recruited the cell's own repair machinery, prime editing replaces it entirely with a programmable molecular typewriter. The cell becomes a substrate; the editor becomes the author. Whether this is progress or hubris depends on how well we understand the substrate.